Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor lipid peroxidation inhibitor from Kirin Brewery

Sep. 27, 1996

Mitsubishi reports isolation of PI 3-kinase inhibitors

Sep. 27, 1996

Prostate cancer treatment approved by the FDA

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Joint venture to develop Biopharmaceutics' orphan anticancer drug

Sep. 27, 1996

First patent for IL-15

Sep. 20, 1996

Pharmacyclics signs manufacturing and supply agreement for texaphyrin products

Sep. 20, 1996

Potential DNA vaccine for B-cell lymphoma

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

New cancer therapy from The Liposome Company advances to full development

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...